Lantheus Holdings (LNTH) Tops Q1 EPS by 6c, Revenues Beat; Raises FY21 EPS/Revenues Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
Go back to Lantheus Holdings (LNTH) Tops Q1 EPS by 6c, Revenues Beat; Raises FY21 EPS/Revenues Guidance
May 3, 2021 8:35 AM EDT
EXINI Diagnostics AB, a subsidiary of Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence (AI) solutions to Find, Fight and Follow serious medical conditions, announced today that it has received CE Mark clearance for aPROMISE in Europe.
aPROMISE is artificial intelligence-based, deep learning-enabled, medical device software that allows healthcare professionals and researchers to perform quantitative assessment of prostate-specific... More
April 30, 2021 8:33 AM EDT
Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced a strategic collaboration with Allegheny Health Network (AHN), a western Pennsylvania healthcare delivery system headquartered in Pittsburgh, PA. Under the agreement, Lantheus microbubbles will be used in combination with AHNs ultrasound-assisted non-viral gene transfer (UAGT) technology for the development of a proposed treatment for xerostomia.
Xerostomia, a lack of saliva production leading to dry mouth, has a variety of causes,... More
